ROSEN, A LEADING LAW FIRM, Encourages Citrix Systems, Inc. Investors With Losses Over $ 100,000 To Obtain Legal Counsel By Important Jan. 18 Deadline In Securities Class Action – CTXS |

NEW YORK, December 5, 2021 / PRNewswire / –

WHY: Rosen Law Firm, a global investor rights law firm, reminds buyers of Citrix Systems, Inc. (NASDAQ: CTXS) securities between January 22, 2020 and October 6, 2021, inclusive (the “Recourse Period”), January 18, 2022 lead applicant time limit.

SO WHAT: If you purchased Citrix securities during the Class Period, you may be entitled to compensation without payment of out-of-pocket expenses or fees under a contingency fee agreement.

WHAT TO DO NEXT: To join the Citrix class action lawsuit, go to or call Phillip Kim, Esq. toll free at 866-767-3653 or by emailing [email protected] or [email protected] for information on the class action. A class action has already been filed. If you wish to act as the principal applicant, you must apply to the Court not later than January 18, 2022. A principal plaintiff is a representative party acting on behalf of the other members of the class to direct the litigation.

WHY THE ROSEN LAW: We encourage investors to select qualified advisors with a track record of success in leadership roles. Often, companies issuing opinions do not have significant experience, resources or recognition by their peers. Many of these companies do not actually litigate class actions in securities. Be wise in choosing a lawyer. Rosen law firm represents investors around the world, focusing its practice on class actions in securities and derivative litigation between shareholders. Rosen law firm has secured the largest securities class action settlement against a Chinese company. Rosen law firm was ranked # 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017. The firm has been ranked in the top 4 every year since 2013 and has recovered hundreds millions of dollars for investors. In 2019 alone, the company achieved more than $ 438 million for investors. In 2020, founding partner Laurence Rosen has been named by law360 as Titan of the Plaintiff’s Bar. Many of the firm’s lawyers have been recognized by Lawdragon and Super Lawyers.

CASE DETAILS: According to the lawsuit, the defendants throughout the litigation period willfully or recklessly made false and misleading representations to the investing public who failed to disclose that the cloud product was substantially similar to the on-premise offering and that the company was experiencing significant difficulties in transitioning customers. from on-premises to the cloud. When the real details entered the market, the lawsuit claims that investors have suffered damage.

To join the Citrix class action lawsuit, go to or call Phillip Kim, Esq. toll free at 866-767-3653 or by emailing [email protected] or [email protected] for information on the class action.

No class has been certified. Until a group is certified, you are not represented by a lawyer unless you hire one. You can choose the lawyer of your choice. You can also remain an absent group member and do nothing at this point. The ability of an investor to participate in any potential future payback does not depend on whether he is a principal applicant.

Follow us for updates on LinkedIn:, on Twitter: or on Facebook:

Lawyer advertising. Previous results do not guarantee a similar result.

Contact details:

Laurence Rosen, Esq.

Phillip Kim, Esq.

Rosen Law Firm, Pennsylvania

275 Madison Avenue, 40th Floor

New York, New York State 10016

Phone. : (212) 686-1060

Toll free: (866) 767-3653

Fax: (212) 202-3827

[email protected]

[email protected]

[email protected]

View original content to download multimedia: -to -conseil-securite-avant-important-January-18-deadline-en-actions-classes-titres – ctxs-301437467.html

SOURCE Rosen Law Firm, PA

Previous Kansas City bands wait months for vinyl records. It's more than a 'supply chain' problem | KCUR 89.3
Next Evaluation of the Equivalence of Different Intakes of Fruitflow to Affect Platelet Aggregation and Thrombin Generating Capacity in a Randomized Double-Blind Pilot Study in Male Subjects | BMC Nutrition